Photo by apsprudente from unsplash
Heparin and low‐molecular‐weight heparin are the preferred anticoagulants during pregnancy as they do not cross the placenta. Although research on the safety of heparin products has been reassuring, previous studies… Click to show full abstract
Heparin and low‐molecular‐weight heparin are the preferred anticoagulants during pregnancy as they do not cross the placenta. Although research on the safety of heparin products has been reassuring, previous studies have considered birth defects as a single outcome or by larger organ system and have not examined associations with specific birth defects.
Keywords:
heparin products;
birth defects;
maternal exposure;
exposure heparin;
birth
Journal Title: Birth Defects Research
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Birth Defects Research
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!